Literature DB >> 28919349

Prevalence of HLA-B*5701 in a Kenyan population with HIV infection.

Reena Shah1, Hilda Nabiswa2, Nancy Okinda3, Gunturu Revathi3, Mark Hawken2, Mark Nelson4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28919349     DOI： 10.1016/j.jinf.2017.09.007

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  2 in total

1.  Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir.

Authors:  Oche O Agbaji; Maxwell O Akanbi; Ihedinachi Otoh; Patricia A Agaba; Rolake Akinsola; Victoria Okolie; Placid O Ugoagwu; Aliyu A Babadoko; Adewumi Adediran; Finomo O Finomo; Jonah O Abah; Haruna M Muktar; Alani S Akanmu
Journal:  Niger Postgrad Med J       Date:  2019 Oct-Dec

2.  Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.

Authors:  Didier K Ekouevi; Serge P Eholie; Malewe Kolou; Armel Poda; Zelica Diallo; Esther Konou; Tatiana Dokpomiwa; Jacques Zoungrana; Mounerou Salou; Lionèle Mba-Tchounga; André Bigot; Abdoul-Salam Ouedraogo; Marielle Bouyout-Akoutet
Journal:  BMC Immunol       Date:  2021-07-22       Impact factor: 3.615
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.